Background: ETRAMP11.2 (PVX_003565) is a well-characterized protein with antigenic potential. It is considered to be a serological marker for diagnostic tools, and it has been suggested as a potential vaccine candidate. Despite its immunological relevance, the polymorphism of theP. vivaxETRAMP11.2 gene (pvetramp11.2) remains undefined. The genetic variability of an antigen may limit the effectiveness of its application as a serological surveillance tool and in vaccine development and, therefore, the aim of this study was to investigate the genetic diversity ofpvetramp11.2in parasite populations from Amazonian regions and worldwide. We also evaluated amino acid polymorphism on predicted B-cell epitopes. The low variability of the sequence en...
Parasite antigen genetic diversity represents a great obstacle when designing a vaccine against mala...
Background: Although a number of Plasmodium vivax proteins have been identified, few have been inves...
Present study describes the characterization of apical membrane antigen 1 (PvAMA1) polymorphisms amo...
Background: The development of malaria vaccine has been hindered by the allele-specific responses pr...
The Plasmodium vivax Cysteine-Rich Protective Antigen (PvCyRPA) has an important role in erythrocyte...
The diversity of MSP1 in both Plasmodium falciparum and P. vivax is presumed be associated to parasi...
Although Plasmodium vivax is a leading cause of malaria around the world, only a handful of vivax an...
Block II of Plasmodium vivax merozoite surface protein 3α (PvMSP3α) is conserved and has been propos...
Background\ud Plasmodium vivax is one of the five species causing malaria in human beings, affecting...
Circumsporozoite protein (CSP) is the primary pre-erythrocytic vaccine target in Plasmodium species....
Abstract. Approximately 55 % of malaria infections in the Guyana Amazon region are attributed to Pla...
<div><p>Transmission-blocking (TB) vaccines are considered an important tool for malaria control and...
Pfs230, surface protein of gametocyte/gamete of the human malaria parasite, Plasmodium falciparum, i...
In Brazil, Plasmodium vivax infection accounts for around 80% of malaria cases. This infection has a...
BACKGROUND: The Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1) is a promising malaria vaccine c...
Parasite antigen genetic diversity represents a great obstacle when designing a vaccine against mala...
Background: Although a number of Plasmodium vivax proteins have been identified, few have been inves...
Present study describes the characterization of apical membrane antigen 1 (PvAMA1) polymorphisms amo...
Background: The development of malaria vaccine has been hindered by the allele-specific responses pr...
The Plasmodium vivax Cysteine-Rich Protective Antigen (PvCyRPA) has an important role in erythrocyte...
The diversity of MSP1 in both Plasmodium falciparum and P. vivax is presumed be associated to parasi...
Although Plasmodium vivax is a leading cause of malaria around the world, only a handful of vivax an...
Block II of Plasmodium vivax merozoite surface protein 3α (PvMSP3α) is conserved and has been propos...
Background\ud Plasmodium vivax is one of the five species causing malaria in human beings, affecting...
Circumsporozoite protein (CSP) is the primary pre-erythrocytic vaccine target in Plasmodium species....
Abstract. Approximately 55 % of malaria infections in the Guyana Amazon region are attributed to Pla...
<div><p>Transmission-blocking (TB) vaccines are considered an important tool for malaria control and...
Pfs230, surface protein of gametocyte/gamete of the human malaria parasite, Plasmodium falciparum, i...
In Brazil, Plasmodium vivax infection accounts for around 80% of malaria cases. This infection has a...
BACKGROUND: The Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1) is a promising malaria vaccine c...
Parasite antigen genetic diversity represents a great obstacle when designing a vaccine against mala...
Background: Although a number of Plasmodium vivax proteins have been identified, few have been inves...
Present study describes the characterization of apical membrane antigen 1 (PvAMA1) polymorphisms amo...